N/A N=61 Randomized Single-blind Treatment

Relationship to Dose of Triamcinolone Acetonide and Methylyprednisolone to Improvement in Subacromial Bursitis

Subacromial Bursitis · Shoulder Pain

Bottom Line

View on ClinicalTrials.gov: NCT02242630 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Dec 2016

Primary outcome: Primary: Change in Shoulder Function, as Measured by the QuickDASH ® — 19.2; 21.3; 19.1; 24.7 units on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Methylprednisolone, 20 mg (Drug); Methylprednisolone, 40 mg (Drug); Triamcinolone, 20 mg (Drug); Triamcinolone, 40 mg (Drug)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Keesler Air Force Base Medical Center
Primary completion: Mar 2016

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Shoulder Function, as Measured by the QuickDASH ®	19.2; 21.3; 19.1; 24.7	—
SECONDARY Change in Subject Reported Shoulder Pain as Measured by the Visual Analogue Scale	1.0; 1.8; 1.9; 1.8	—

Summary

It is currently unknown whether or not the improvement in pain and function related to a "steroid shot" for shoulder pain due to subacromial bursitis is important. This study seeks to determine whether 20 mg or 40 mg of either triamcinolone or methylprednisolone significantly affect improvement in shoulder pain 6 weeks after injection.

Eligibility Criteria

Inclusion Criteria

Age 18 years or older
History and physical examination consistent with shoulder pain and subacromial bursitis
At least 2 weeks of shoulder pain and subacromial bursitis

Exclusion Criteria

Known allergies to Lidocaine, Marcaine, Methylprednisolone, and/or Triamcinolone
History or examination suspicious for a humeral head fracture
History or examination consistent with adhesive capsulitis (normal X-Ray of the shoulder but with less than 100 degrees of active or passive elevation of the arm, when raising the arm above the head to a maximum with passive external rotation being 50 degrees less than the unaffected side
History or examination consistent with acute synovitis of the glenohumeral or acromioclavicular joint
Any shoulder surgery involving the affected arm within the last 6 months

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02242630). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.